PALATIN TECHNOLOGIES Forum: Community User: CologneFC

Was für ein run

denke 1$ könnte erstmal einen Widerstand markieren- wäre dann 88 Cent

Mein Gefühl sagt mir es geht weiter hoch ☝️

So I think that Vyleesi falls into a category where you're characterizing the blood pressure effect. The clinical risk is low and probably I don't think that they would necessarily have to go out and seek advice from an adcom. I think that the personnel that we've been working with the agency that are coming from the cardio legal group or are quite conversant with the type of study signs we're using and the potential risk of intermittent changes, small change in blood pressure. So I think that we're okay there. However, with that being said, we will be submitting the data back. The agency has the right to take -- to have additional time to review that data should they choose to do so. I don't think at the moment based on our discussions with them, that they will do that, but we always have to plan for that, that they could. Wieder Steve Willis, PTN

Steve Wills As Carl mentioned, the AI that we needed was, we needed more specificity, granularity around the specific protocol for approval in Europe. We have that now and as Carl mentioned, we were pleased with the response and the dialogue from IMA/CHMP. So that activity has definitely increased, not just us calling, but also inbound calls. We're actively and aggressively in discussions with all the regions outside of the already licensed territories of North America with AMAG, China with Fosun and South Korea with Kwangdong Pharmaceuticals. So we and as we get closer to the PDUFA date and the approval I'm very comfortable that these discussions will even advanced greater. We're also working closely with our existing rest of the world partners i.e. Fosun, Pharma and Kwangdong. They are in active discussions with the related regulatory FDI in China and the same equivalent in South Korea on planning their specific regulatory path. So we're very excited and enthusiastic with the activity and the interest and with the assumption and caveat that were approved in June. We would anticipate that frankly all the regions outside the existing territories would be licensed before the end of calendar 2019.

Was meint Ihr, korrigieren wir nochmal unter 80 Cent? Bin gespannt was die Amis heute draus machen :-)

Alter Schwede gehts wieder ab

Ich habe mein Addon von 23000 shares vonvor zwei Tagen erstmal wieder mit dem Gewinn von gestern über Bord geworfen. Wenn ich da nochmal billiger wieder reinkomme gut, wenn nicht ist es gut für meine ohnehin große long Position :-) - so oder so - geil Palatin !!!

Überzeugt 😛 ich bleib drin

PALATIN TECHNOLOGIES, INC. (PTN) REPORT OVERVIEW Palatin Technologies' Recent Financial Performance For the twelve months ended June 30th, 2018 vs June 30th, 2017, Palatin Technologies reported revenue of $67.13MM vs $44.72MM (up 50.11%) and analysts estimated basic earnings per share $0.12 vs -$0.07. Analysts expect earnings to be released on May 21st, 2019. The report will be for the fiscal period ending March 31st, 2019. Reported EPS for the same quarter last year was $0.00. The estimated EPS forecast for the next fiscal year is $0.16 and is expected to report on September 12th, 2019. To read the full Palatin Technologies, Inc. (PTN) report, download it here: http://Fundamental-Markets.com/register/?so=PTN

Ist doch unklug jetzt auszusteigen, klar kann man Glück haben, aber die Richtung bis Ende Juni sollte jedem klar sein. Wozu also unnötiger Stress.

Zum Einstieg war genügend Zeit 😉

Ja lass mich gerne überraschen :)

@Abgehoben, wenn du da mal nicht falsch liegst. 😉

40% plus. Glaub ich geh mal raus. Ob das noch weiter steigt in den nächsten Tagen?

Aber kann man dann nochmal gut nachlegen:)